MY177993A - Agent for ameliorating allergy - Google Patents
Agent for ameliorating allergyInfo
- Publication number
- MY177993A MY177993A MYPI2015701404A MYPI2015701404A MY177993A MY 177993 A MY177993 A MY 177993A MY PI2015701404 A MYPI2015701404 A MY PI2015701404A MY PI2015701404 A MYPI2015701404 A MY PI2015701404A MY 177993 A MY177993 A MY 177993A
- Authority
- MY
- Malaysia
- Prior art keywords
- agent
- galactopyranosyl
- ameliorating
- allergies
- ameliorating allergies
- Prior art date
Links
- 206010020751 Hypersensitivity Diseases 0.000 title abstract 5
- 230000007815 allergy Effects 0.000 title abstract 5
- 208000026935 allergic disease Diseases 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 abstract 1
- 150000003271 galactooligosaccharides Chemical class 0.000 abstract 1
- 230000004957 immunoregulator effect Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/14—Pretreatment of feeding-stuffs with enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Husbandry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention provides an agent for ameliorating allergies, which inhibits secretion of inflammatory cytokines to ameliorate in vivo immunoregulatory disorders, and products, such as food nd drink, feed, and pharmaceutical product for ameliorating allergies containing the agent for ameliorating allergies. The agent for ameliorating allergies comprises, as an active ingredient, galactooligosaccharide having a structure represented by the formula o-?-D-galactopyranosyl-(1-6)-[0- -D-galactopyranosyl-(1-4)]-D-glucose or o-?-D-galactopyranosyl-(1-4)-[0- -D-galactopyranosyl-(1-6)]-D-glucose.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012253718A JP6072516B2 (en) | 2012-11-19 | 2012-11-19 | Allergy improving agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY177993A true MY177993A (en) | 2020-09-28 |
Family
ID=50731291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2015701404A MY177993A (en) | 2012-11-19 | 2013-11-18 | Agent for ameliorating allergy |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JP6072516B2 (en) |
| CN (1) | CN104797260A (en) |
| HK (1) | HK1207311A1 (en) |
| MY (1) | MY177993A (en) |
| TW (1) | TW201427603A (en) |
| WO (1) | WO2014077383A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1246600B (en) * | 2015-01-26 | 2020-04-09 | Cadena Bio, Inc. | Oligosaccharide compositions for use animal feed and methods of producing thereof |
| JP6579603B2 (en) * | 2015-05-20 | 2019-09-25 | 再生ファーマ株式会社 | Preventive / ameliorating agent for allergic diseases |
| AU2019334595B2 (en) * | 2018-09-05 | 2024-11-28 | Saisei Pharma Co., Ltd. | Inflammatory cytokine production inhibitor |
| DE102020133860A1 (en) | 2020-12-16 | 2022-06-23 | MNT Systeme GmbH | USE OF β-GALACTOOLIGOSACCHRIDS FOR THE PREPARATION OF A COSMETIC AND/OR PHARMACOLOGICALLY ACTIVE COMPOSITION |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2904687B2 (en) * | 1993-09-17 | 1999-06-14 | 雪印乳業株式会社 | New oligosaccharide |
| JP2000060541A (en) * | 1998-08-27 | 2000-02-29 | Fuyuki Mitsuyama | Bifidobacterium proliferation-promoting substance, intestinal function-controlling substance and pharmaceutical preparation for bifidobacterium |
| JP4719850B2 (en) * | 2004-11-12 | 2011-07-06 | 熊本県 | Bifidobacterium growth-promoting composition |
| ES2369789T3 (en) * | 2005-04-21 | 2011-12-07 | The Hokuren Federation Of Agricultural Cooperatives | 1-KESTOSA TO TREAT ALLERGIES AND ATOPIC DERMATITIS. |
| JP4844922B2 (en) * | 2006-01-24 | 2011-12-28 | 日新製糖株式会社 | Allergic constitution improving composition |
| JP2009114080A (en) * | 2007-11-02 | 2009-05-28 | Icreo Co Ltd | Composition for treating atopic dermatitis |
-
2012
- 2012-11-19 JP JP2012253718A patent/JP6072516B2/en active Active
-
2013
- 2013-11-18 HK HK15108025.5A patent/HK1207311A1/en unknown
- 2013-11-18 CN CN201380060243.8A patent/CN104797260A/en active Pending
- 2013-11-18 WO PCT/JP2013/081016 patent/WO2014077383A1/en not_active Ceased
- 2013-11-18 MY MYPI2015701404A patent/MY177993A/en unknown
- 2013-11-19 TW TW102142097A patent/TW201427603A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1207311A1 (en) | 2016-01-29 |
| WO2014077383A1 (en) | 2014-05-22 |
| TW201427603A (en) | 2014-07-16 |
| CN104797260A (en) | 2015-07-22 |
| JP6072516B2 (en) | 2017-02-01 |
| JP2014101305A (en) | 2014-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021015106A (en) | Novel ferroportin inhibitors. | |
| TN2015000278A1 (en) | Autotaxin inhibitors | |
| PH12016500094A1 (en) | Autotaxin inhibitors | |
| IN2014DN09805A (en) | ||
| MX2014014711A (en) | N-aryltriazole compounds as lpar antagonists. | |
| IN2014DN09804A (en) | ||
| TN2014000185A1 (en) | Polyethylene glycol based prodrug of adrenomedullin and use thereof | |
| MX2014014710A (en) | N-alkyltriazole compounds as lpar antagonists. | |
| GEP20186899B (en) | 6 - alkynyl pyridines as smac mimetics | |
| IN2014DN07322A (en) | ||
| MX2016013029A (en) | Substituted indanone compounds as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders. | |
| MX357284B (en) | Quinone compounds for treating ape1 mediated diseases. | |
| WO2010147440A3 (en) | Health food or pharmaceutical composition comprising chestnut shell extract | |
| MX2016004934A (en) | Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy. | |
| MY177993A (en) | Agent for ameliorating allergy | |
| MX2015005732A (en) | Tricyclic compounds and methods of making and using same. | |
| MX2013013436A (en) | Substituted indole derivatives for the treatment of immunological disorders. | |
| MX364652B (en) | Pharmaceutical formulation comprising ciclesonide. | |
| IN2015DN02296A (en) | ||
| MY186332A (en) | Pentosidine production inhibitor | |
| MX362533B (en) | Combination of somatostatin-analogs with 11beta-hydroxylase inhibitors. | |
| MX2014006201A (en) | Imatinib solid dosage forms reconstituted just before use. | |
| WO2014122671A3 (en) | Solid oral compositions of saxagliptin | |
| PH12012000220A1 (en) | Solid pharmaceutical composition for buccal administration of agomelatine | |
| UA105703C2 (en) | 7-bromo-5-phenyl-3-arylamino-1,2-dihydro-3h-1,4-benzdiazepin-2-ones as analgetic agents |